Covid-19 tablet remedy highly efficient at preventing hospitalisation, dying

A prominent Thai virologist says the world’s first oral remedy for Covid-19 is extremely effective if taken within 5 days of signs developing. Dr Yong Poovorawan from the Centre of Excellence in Clinical Virology at Chulalongkorn University made the statement on his Facebook web page yesterday. According to a Bangkok Post report, he was citing research revealed on the well being sciences website, medRxiv.
“Molnupiravir is the first oral, direct-acting antiviral proven to be extremely efficient at decreasing nasopharyngeal SARS-CoV-2 infectious virus and viral RNA and has a favourable safety and tolerability profile.”

Yong says the Molnupiravir capsule, developed by pharmaceutical agency Merck, can cut back the chance of hospitalisation or death in Covid-19 patients. The medicine is presently awaiting approval from the US Food and Drug Administration. The Bangkok Post reviews that 5 pharmaceutical companies in India have been authorised to manufacture Molnupiravir, which Yong says ought to make the remedy extra affordable.
Treasure of Molnupiravir is proving a contentious problem, with one Thai activist filing a criticism towards the Public Health Ministry, the Department of Medical Services, and the Thai Food and Drug Administration. Nimit Tienudom lodged the grievance on October 15, protesting the high value of the drug, which it’s understood has been set at 23,000 per course of remedy.
Other civil groups have voiced frustration that the Public Health Ministry has up to now solely negotiated with Merck. They say that while this was carried out for the first 200,000 remedy programs, the government ought to now shift to negotiating with the Indian producers so as to make future therapy more reasonably priced.
For extra data on Covid-19 Insurance, CLICK HERE..

Leave a Comment